Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Detroit | 7,233 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,233 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2321-2340 of 7,233 trials

CompletedEfficacy of NovoSeven® in Bleeding Prophylaxis in HemophiliaThis trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA).NCT00108758·Berkeley, California and 36 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

CompletedSemaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityThe researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular…NCT03574597·Birmingham, Alabama and 832 others

CompletedA Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerThe purpose of this study is to determine whether ramucirumab when used in conjunction with chemotherapy treatment can help participants with stomach, esophagus, and…NCT01246960·Anchorage, Alaska and 57 others

Active not recruitingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyThis phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the…NCT04071223·Birmingham, Alabama and 46 others

CompletedStudy Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyThe purpose of this study is to compare the safety and effectiveness of different doses of an investigational medication in women with severe diarrhea-predominant Irritable Bowel…NCT00067561·Birmingham, Alabama and 177 others

WithdrawnA Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid TumorThe reason for this study is to see if the CD73 inhibitor HLX23 alone is safe and effective in participants with advanced solid cancer.NCT04797468·Los Angeles, California and 5 others

CompletedStudy of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoclax vs. ibrutinib and placebo…NCT03112174·Tucson, Arizona and 119 others

RecruitingA Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabThis phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard…NCT05675410·Birmingham, Alabama and 414 others

TerminatedStudy of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung CancerThis open-label, non-randomized Phase II trial is designed to assess the safety and tolerability of GT103 in combination with pembrolizumab in adult subjects with relapsed or…NCT05617313·Chicago, Illinois and 5 others

CompletedA Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersThe clinical trial was a companion study to protocol CL-PTL-119 (A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell…NCT03073525·Mobile, Alabama and 5 others

CompletedPhase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in PatientsThis is a multi center, open-label study to evaluate the drug-drug interaction of LDE225 on the PK of bupropion and warfarin patients with advanced solid tumors.NCT01769768·Duarte, California and 12 others

RecruitingA Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload…NCT06926868·Hot Springs, Arkansas and 294 others

TerminatedOfatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to RituxtherapyThe purpose of this study was to evaluate the safety and efficacy of ofatumumab and bendamustine combination therapy in patients with indolent B-cell NHL that did not respond to…NCT01077518·Tucson, Arizona and 139 others

CompletedA Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsThis is a study to determine the clinical benefit (how well the drug works), safety, and tolerability of combining varlilumab and nivolumab (also known as Opdivo® , BMS-936558).NCT02335918·Tucson, Arizona and 18 others

CompletedTRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureTRANSFORM-HF is a large-scale, pragmatic, randomized, unblinded clinical effectiveness study comparing torsemide versus furosemide as treatment for heart failure.NCT03296813·Alexander City, Alabama and 59 others

CompletedStudy of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced CancersThe primary objectives in the dose escalation phase are to evaluate safety and pharmacokinetics (PK) in order to determine the selected dose level(s) for expansion of REGN3767 as…NCT03005782·Encinitas, California and 42 others

CompletedDonor Milk vs. Formula in Extremely Low Birth Weight (ELBW) InfantsThe Milk Trial seeks to determine the effect on neurodevelopmental outcomes at age 22-26 months of donor human milk as compared to preterm infant formula as the in-hospital diet…NCT01534481·Birmingham, Alabama and 16 others

CompletedStudy to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)The primary objective of this study is to evaluate the safety and tolerability and virologic response of tenofovir alafenamide (TAF) in virologically suppressed chronic hepatitis…NCT03180619·Los Angeles, California and 29 others

RecruitingComparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter DefibrillatorThis prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in…NCT06964464·Scottsdale, Arizona and 12 others

RecruitingInotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic LeukemiaThis phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic…NCT03739814·Birmingham, Alabama and 279 others

PreviousPage 117 of 362Next

in Detroit

Heart Diseasein Detroit